Green Cross, Stock Price +16.27% at This Time... 55,526 Shares Net Sold by Individuals in the Last 5 Days

As of 1:31 PM on the 13th, Green Cross is trading at 196,500 KRW, up 16.27% from the previous day. The trading volume is 1,243,340 shares, which is 177.06% of the previous day's volume. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

On July 10, Minjeong Seon, a researcher at Hana Financial Investment, stated, "The second-quarter earnings were weak due to being pre-reflected in the first quarter and deferred to the third quarter. Due to the expansion of flu vaccine vaccinations caused by the COVID-19 virus, record-high third-quarter earnings are expected, and Green Cross, which is also developing a COVID-19 plasma treatment, can be considered a true beneficiary stock of COVID-19." She set Green Cross's target price at 240,000 KRW.

Over the past five days, individual investors have net sold 55,526 shares of Green Cross, while foreigners and institutions have net bought 40,368 shares and 11,441 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.